Abstract:【Objective】 To study the effect of arthroscopic debridement on knee joint function and life quality of osteoarthritis patients. 【Methods】 70 cases of osteoarthritis patients in our hospital from 2013 January to 2014 January were randomly divided into observation group and control group. Observation group received arthroscopic debridement, control group received meloxicam oral therapy. Then joint function, quality of life as well as MMPs content in synovial fluid were compared. 【Results】 Joint function: observation group WOMAC osteoarthritis index were lower than those of control group [(41.45 ± 6.83) vs (57.52 ± 7.05)]; Lysholm score and Tenger score were higher than those of control group [(72.32 ± 10.41) vs (58.42 ± 8.92), (5.49 ± 0.68) vs (4.21 ± 0.62)]; quality of life: observation group physical health, mental health, social function, material conditions score were higher than those of control group [(59.82 ± 9.61) vs (45.27 ± 8.33), (66.03 ± 7.52) vs (52.17 ± 5.93), (67.65 ± 8.34) vs (54.01 ± 6.72), (58.23 ± 7.16) vs (51.29 ± 5.32)]; MMPs content in synovial fluid: observation group MMP1, MMP3 content in synovial fluid were lower than those of control group [(1.05 ± 0.12) vs (1.73 ± 0.22), (14.73 ± 1.78) vs (25.72 ± 3.18)]. 【Conclusion】 Arthroscopic debridement can help improve the joint function and improve the quality of life and reduce the content of MMP1 and MMP3 in synovial fluid of patients with non symptomatic knee osteoarthritis.